Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Jul;80(1):216–225. doi: 10.1172/JCI113050

Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy.

P Pinkston, V K Vijayan, T B Nutman, W N Rom, K M O'Donnell, M J Cornelius, V Kumaraswami, V J Ferrans, T Takemura, G Yenokida, et al.
PMCID: PMC442221  PMID: 3298321

Abstract

Although acute tropical pulmonary eosinophilia (TPE) is well recognized as a manifestation of filarial infection, the processes that mediate the abnormalities of the lung in TPE are unknown. To evaluate the hypothesis that the derangements of the lower respiratory tract in this disorder are mediated by inflammatory cells in the local milieu, we utilized bronchoalveolar lavage to evaluate affected individuals before and after therapy. Inflammatory cells recovered from the lower respiratory tract of individuals with acute, untreated TPE (n = 8) revealed a striking eosinophilic alveolitis, with marked elevations in both the proportion of eosinophils (TPE 54 +/- 5%; normal 2 +/- 5%; P less than 0.001) and the concentration of eosinophils in the recovered epithelial lining fluid (ELF) (TPE 63 +/- 20 X 10(3)/microliter; normal 0.3 +/- 0.1 X 10(3)/microliter; P less than 0.01). Importantly, when individuals (n = 5) with acute TPE were treated with diethylcarbamazine (DEC), there was a marked decrease of the lung eosinophils and concomitant increase in lung function. These observations are consistent with the concept that at least some of the abnormalities found in the lung in acute TPE are mediated by an eosinophil-dominated inflammatory process in the lower respiratory tract.

Full text

PDF
216

Images in this article

220Image
on p.220
220Image
on p.220
220Image
on p.220
220Image
on p.220
221Image
on p.221
221Image
on p.221
221Image
on p.221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayars G. H., Altman L. C., Gleich G. J., Loegering D. A., Baker C. B. Eosinophil- and eosinophil granule-mediated pneumocyte injury. J Allergy Clin Immunol. 1985 Oct;76(4):595–604. doi: 10.1016/0091-6749(85)90781-x. [DOI] [PubMed] [Google Scholar]
  2. Clark R. A., Gallin J. I., Kaplan A. P. The selective eosinophil chemotactic activity of histamine. J Exp Med. 1975 Dec 1;142(6):1462–1476. doi: 10.1084/jem.142.6.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohen S., Ward P. A. In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J Exp Med. 1971 Jan 1;133(1):133–146. doi: 10.1084/jem.133.1.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colley D. G. Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol. 1973 May;110(5):1419–1423. [PubMed] [Google Scholar]
  5. Cotes J. E., Dabbs J. M., Hall A. M., Lakhera S. C., Saunders M. J., Malhotra M. S. Lung function of healthy young men in India: contributory roles of genetic and environmental factors. Proc R Soc Lond B Biol Sci. 1975 Dec 2;191(1104):413–425. doi: 10.1098/rspb.1975.0136. [DOI] [PubMed] [Google Scholar]
  6. Crystal R. G., Bitterman P. B., Rennard S. I., Hance A. J., Keogh B. A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med. 1984 Jan 19;310(3):154–166. doi: 10.1056/NEJM198401193100304. [DOI] [PubMed] [Google Scholar]
  7. Crystal R. G., Bitterman P. B., Rennard S. I., Hance A. J., Keogh B. A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med. 1984 Jan 26;310(4):235–244. doi: 10.1056/NEJM198401263100406. [DOI] [PubMed] [Google Scholar]
  8. Czarnetzki B. M. In vitro generation of eosinophil chemotactic factor from human and murine mononuclear phagocytes. Scand J Immunol. 1981;13(6):511–516. doi: 10.1111/j.1365-3083.1981.tb00164.x. [DOI] [PubMed] [Google Scholar]
  9. Danaraj T. J., Pacheco G., Shanmugaratnam K., Beaver P. C. The etiology and pathology of eosinophilic lung (tropical eosinophilia). Am J Trop Med Hyg. 1966 Mar;15(2):183–189. doi: 10.4269/ajtmh.1966.15.183. [DOI] [PubMed] [Google Scholar]
  10. Davis W. B., Fells G. A., Sun X. H., Gadek J. E., Venet A., Crystal R. G. Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J Clin Invest. 1984 Jul;74(1):269–278. doi: 10.1172/JCI111411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fauci A. S., Harley J. B., Roberts W. C., Ferrans V. J., Gralnick H. R., Bjornson B. H. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med. 1982 Jul;97(1):78–92. doi: 10.7326/0003-4819-97-1-78. [DOI] [PubMed] [Google Scholar]
  12. Fox B., Seed W. A. Chronic eosinophilic pneumonia. Thorax. 1980 Aug;35(8):570–580. doi: 10.1136/thx.35.8.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Frigas E., Loegering D. A., Gleich G. J. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest. 1980 Jan;42(1):35–43. [PubMed] [Google Scholar]
  14. Frigas E., Loegering D. A., Solley G. O., Farrow G. M., Gleich G. J. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc. 1981 Jun;56(6):345–353. [PubMed] [Google Scholar]
  15. Fulmer J. D., Roberts W. C., von Gal E. R., Grystal R. G. Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. J Clin Invest. 1977 Sep;60(3):595–610. doi: 10.1172/JCI108811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979 Dec;123(6):2925–2927. [PubMed] [Google Scholar]
  17. Gleich G. J., Loegering D. A. Immunobiology of eosinophils. Annu Rev Immunol. 1984;2:429–459. doi: 10.1146/annurev.iy.02.040184.002241. [DOI] [PubMed] [Google Scholar]
  18. Godard P., Chaintreuil J., Damon M., Coupe M., Flandre O., Crastes de Paulet A., Michel F. B. Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. J Allergy Clin Immunol. 1982 Aug;70(2):88–93. doi: 10.1016/0091-6749(82)90234-2. [DOI] [PubMed] [Google Scholar]
  19. Goetzl E. J., Austen K. F. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci U S A. 1975 Oct;72(10):4123–4127. doi: 10.1073/pnas.72.10.4123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gosset P., Tonnel A. B., Joseph M., Prin L., Mallart A., Charon J., Capron A. Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients. J Allergy Clin Immunol. 1984 Dec;74(6):827–834. doi: 10.1016/0091-6749(84)90186-6. [DOI] [PubMed] [Google Scholar]
  21. Grantham J. G., Meadows J. A., 3rd, Gleich G. J. Chronic eosinophilic pneumonia. Evidence for eosinophil degranulation and release of major basic protein. Am J Med. 1986 Jan;80(1):89–94. doi: 10.1016/0002-9343(86)90053-7. [DOI] [PubMed] [Google Scholar]
  22. Greene B. M., Taylor H. R., Aikawa M. Cellular killing of microfilariae of Onchocerca volvulus: eosinophil and neutrophil-mediated immune serum-dependent destruction. J Immunol. 1981 Oct;127(4):1611–1618. [PubMed] [Google Scholar]
  23. Haslam P. L., Turton C. W., Heard B., Lukoszek A., Collins J. V., Salsbury A. J., Turner-Warwick M. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax. 1980 Jan;35(1):9–18. doi: 10.1136/thx.35.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hunninghake G. W., Gadek J. E., Kawanami O., Ferrans V. J., Crystal R. G. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol. 1979 Oct;97(1):149–206. [PMC free article] [PubMed] [Google Scholar]
  25. Hunninghake G. W., Kawanami O., Ferrans V. J., Young R. C., Jr, Roberts W. C., Crystal R. G. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):407–412. doi: 10.1164/arrd.1981.123.4.407. [DOI] [PubMed] [Google Scholar]
  26. Hussain R., Hamilton R. G., Kumaraswami V., Adkinson N. F., Jr, Ottesen E. A. IgE responses in human filariasis. I. Quantitation of filaria-specific IgE. J Immunol. 1981 Oct;127(4):1623–1629. [PubMed] [Google Scholar]
  27. Joshi V. V., Udwadia F. E., Gadgil R. K. Etiology of tropical eosinophilia. A study of lung biopsies and review of published reports. Am J Trop Med Hyg. 1969 Mar;18(2):231–240. [PubMed] [Google Scholar]
  28. Kamat S. R., Warrier N. V., Store S. D., Karandikar K. N., D'Sa E., Hoskote V. R. Clinical studies in pulmonary eosinophilia. I--Comparative study of response to diethylcarbamazine and cortico-steroid drugs. Indian J Chest Dis Allied Sci. 1976 Oct;18(4):221–232. [PubMed] [Google Scholar]
  29. Kanner R. E., Hammar S. P. Chronic eosinophilic pneumonia. Ultrastructural evidence of marked immunoglobulin production plus macrophagic ingestion of eosinophils and eosinophilic lysosomes leading to intracytoplasmic Charcot-Leyden crystals. Chest. 1977 Jan;71(1):95–98. doi: 10.1378/chest.71.1.95. [DOI] [PubMed] [Google Scholar]
  30. Kay A. B. Eosinophils as effector cells in immunity and hypersensitivity disorders. Clin Exp Immunol. 1985 Oct;62(1):1–12. [PMC free article] [PubMed] [Google Scholar]
  31. Kay A. B. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin Exp Immunol. 1970 Nov;7(5):723–737. [PMC free article] [PubMed] [Google Scholar]
  32. Kephart G. M., Gleich G. J., Connor D. H., Gibson D. W., Ackerman S. J. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. Lab Invest. 1984 Jan;50(1):51–61. [PubMed] [Google Scholar]
  33. King C. H., Greene B. M., Spagnuolo P. J. Diethylcarbamazine citrate, an antifilarial drug, stimulates human granulocyte adherence. Antimicrob Agents Chemother. 1983 Sep;24(3):453–456. doi: 10.1128/aac.24.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. McEvoy J. D., Donald K. J., Edwards R. L. Immunoglobulin levels and electron microscopy in eosinophilic pneumonia. Am J Med. 1978 Mar;64(3):529–536. doi: 10.1016/0002-9343(78)90248-6. [DOI] [PubMed] [Google Scholar]
  35. Neva F. A., Kaplan A. P., Pacheco G., Gray L., Danaraj T. J. Tropical eosinophilia. A human model of parasitic immunopathology, with observations on serum IgE levels before and after treatment. J Allergy Clin Immunol. 1975 Jun;55(6):422–429. doi: 10.1016/0091-6749(75)90081-0. [DOI] [PubMed] [Google Scholar]
  36. Neva F. A., Ottesen E. A. Tropical (filarial) eosinophilia. N Engl J Med. 1978 May 18;298(20):1129–1131. doi: 10.1056/NEJM197805182982006. [DOI] [PubMed] [Google Scholar]
  37. Nutman T. B., Ottesen E. A., Fauci A. S., Volkman D. J. Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function. J Clin Invest. 1984 Jun;73(6):1754–1762. doi: 10.1172/JCI111384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ottesen E. A. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Rev Infect Dis. 1985 May-Jun;7(3):341–356. doi: 10.1093/clinids/7.3.341. [DOI] [PubMed] [Google Scholar]
  39. Ottesen E. A. Immunological aspects of lymphatic filariasis and onchocerciasis in man. Trans R Soc Trop Med Hyg. 1984;78 (Suppl):9–18. doi: 10.1016/0035-9203(84)90309-2. [DOI] [PubMed] [Google Scholar]
  40. Ottesen E. A., Neva F. A., Paranjape R. S., Tripathy S. P., Thiruvengadam K. V., Beaven M. A. Specific allergic sensitsation to filarial antigens in tropical eosinophilia syndrome. Lancet. 1979 Jun 2;1(8127):1158–1161. doi: 10.1016/s0140-6736(79)91842-7. [DOI] [PubMed] [Google Scholar]
  41. Piessens W. F., Beldekas M. Diethylcarbamazine enhances antibody-mediated cellular adherence to Brugia malayi microfilariae. Nature. 1979 Dec 20;282(5741):845–847. doi: 10.1038/282845a0. [DOI] [PubMed] [Google Scholar]
  42. Poh S. C. The course of lung function in treated tropical pulmonary eosinophilia. Thorax. 1974 Nov;29(6):710–712. doi: 10.1136/thx.29.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rennard S. I., Basset G., Lecossier D., O'Donnell K. M., Pinkston P., Martin P. G., Crystal R. G. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985) 1986 Feb;60(2):532–538. doi: 10.1152/jappl.1986.60.2.532. [DOI] [PubMed] [Google Scholar]
  44. Rácz P., Tenner-Rácz K., Büttner D. W., Albiez E. J. Ultrastructural evidence for eosinophil-parasite adherence (EPA) reaction in human onchocercal lymphadenitis in the early period following diethylcarbamazine treatment. Tropenmed Parasitol. 1982 Dec;33(4):213–218. [PubMed] [Google Scholar]
  45. Saltini C., Hance A. J., Ferrans V. J., Basset F., Bitterman P. B., Crystal R. G. Accurate quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis. 1984 Oct;130(4):650–658. doi: 10.1164/arrd.1984.130.4.650. [DOI] [PubMed] [Google Scholar]
  46. Songsiridej V., Peters M. S., Dor P. J., Ackerman S. J., Gleich G. J., Busse W. W. Facial edema and eosinophilia. Evidence for eosinophil degranulation. Ann Intern Med. 1985 Oct;103(4):503–506. doi: 10.7326/0003-4819-103-4-503. [DOI] [PubMed] [Google Scholar]
  47. Spry C. J., Kumaraswami V. Tropical eosinophilia. Semin Hematol. 1982 Apr;19(2):107–115. [PubMed] [Google Scholar]
  48. Staniunas R. J., Hammerberg B. Diethylcarbamazine-enhanced activation of complement by intact microfilariae of Dirofilaria immitis and their in vitro products. J Parasitol. 1982 Oct;68(5):809–816. [PubMed] [Google Scholar]
  49. Tai P. C., Spry C. J. Studies on blood eosinophils. I. Patients with a transient eosinophilia. Clin Exp Immunol. 1976 Jun;24(3):415–422. [PMC free article] [PubMed] [Google Scholar]
  50. Tanaka J., Baba T., Torisu M. Ascaris and eosinophil. II. Isolation and characterization of eosinophil chemotactic factor and neutrophil chemotactic factor of parasite in Ascaris antigen. J Immunol. 1979 Jan;122(1):302–308. [PubMed] [Google Scholar]
  51. Tsuda S., Fukuyama K., Epstein W. L. Eosinophil response in guinea pig skin to a low molecular weight eosinophil chemotactic factor extracted from livers of mice with schistosomiasis. J Invest Dermatol. 1980 Apr;74(4):216–218. doi: 10.1111/1523-1747.ep12541745. [DOI] [PubMed] [Google Scholar]
  52. Udwadia F. E. Tropical eosinophilia. A correlation of clinical, histopathologic and lung function studies. Dis Chest. 1967 Oct;52(4):531–538. doi: 10.1378/chest.52.4.531. [DOI] [PubMed] [Google Scholar]
  53. WEBB J. K., JOB C. K., GAULT E. W. Tropical eosinophilia: demonstration of microfilariae in lung, liver, and lymphnodes. Lancet. 1960 Apr 16;1(7129):835–842. doi: 10.1016/s0140-6736(60)90730-3. [DOI] [PubMed] [Google Scholar]
  54. Wadee A. A., Sher R. The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration. Immunology. 1980 Dec;41(4):989–995. [PMC free article] [PubMed] [Google Scholar]
  55. Weller P. F., Goetzl E. J. The human eosinophil: roles in host defense and tissue injury. Am J Pathol. 1980 Sep;100(3):791–820. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES